Trial Profile
Clinical Trials Insight: 700029922
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 16 Jan 2008
Price :
$35
*
At a glance
- Drugs NUC B1000 (Primary)
- Indications Hepatitis B
- Focus Adverse reactions
- Sponsors Nucleonics
- 16 Jan 2008 New trial record.